Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Su

Showing results (51-60 of 60) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 60 results.
Journal of the American College of Cardiology|April 10, 2010
Efficacy and safety of mipomersen, an antisense inhibitor of apolipoprotein B, in hypercholesterolemic subjects receiving stable statin therapyFatima Akdim, Erik S G Stroes, Eric J G Sijbrands, et al.
Vaccine|June 5, 2021
U.S. Population-Based background incidence rates of medical conditions for use in safety assessment of COVID-19 vaccinesDiane Gubernot, Amelia Jazwa, Manette Niu, et al.
The Journal of Infectious Diseases|April 9, 2009
Outbreak of severe respiratory disease associated with emergent human adenovirus serotype 14 at a US air force training facility in 2007Jacqueline E Tate, Michel L Bunning, Lisa Lott, et al.
The Australasian Journal of Dermatology|March 11, 2015
Adverse effects of topical corticosteroids in paediatric eczema: Australasian consensus statementEmma Mooney, Marius Rademaker, Rebecca Dailey, et al.
Journal of the American Academy of Dermatology|February 26, 2018
CARD14-associated papulosquamous eruption: A spectrum including features of psoriasis and pityriasis rubra pilarisBrittany G Craiglow, Lynn M Boyden, Ronghua Hu, et al.
American Journal of Human Genetics|March 5, 2016
Mosaic Activating Mutations in FGFR1 Cause Encephalocraniocutaneous LipomatosisJames T Bennett, Tiong Yang Tan, Diana Alcantara, et al.
The Australasian Journal of Dermatology|March 3, 2017
Consensus statement for the treatment of infantile haemangiomas with propranololSarah L Smithson, Marius Rademaker, Susan Adams, et al.
Journal of the American Academy of Dermatology|July 19, 2020
Multidisciplinary care of epidermolysis bullosa during the COVID-19 pandemic-Consensus: Recommendations by an international panel of expertsDedee F Murrell, Anne W Lucky, Julio C Salas-Alanis, et al.
The New England Journal of Medicine|February 19, 2015
A randomized, controlled trial of oral propranolol in infantile hemangiomaChristine Léauté-Labrèze, Peter Hoeger, Juliette Mazereeuw-Hautier, et al.
The World Allergy Organization Journal|August 30, 2024
The Australasian Registry for Severe Cutaneous Adverse Reactions (AUS-SCAR) - Providing a roadmap for closing the diagnostic, patient, and healthcare gaps for a group of rare drug eruptionsFiona James, Michelle S Goh, Sara Vogrin, et al.
Pageof 6

Showing results (51-60 of 60) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 60 results.
Journal of the American College of Cardiology|April 10, 2010
Efficacy and safety of mipomersen, an antisense inhibitor of apolipoprotein B, in hypercholesterolemic subjects receiving stable statin therapyFatima Akdim, Erik S G Stroes, Eric J G Sijbrands, et al.
Vaccine|June 5, 2021
U.S. Population-Based background incidence rates of medical conditions for use in safety assessment of COVID-19 vaccinesDiane Gubernot, Amelia Jazwa, Manette Niu, et al.
The Journal of Infectious Diseases|April 9, 2009
Outbreak of severe respiratory disease associated with emergent human adenovirus serotype 14 at a US air force training facility in 2007Jacqueline E Tate, Michel L Bunning, Lisa Lott, et al.
The Australasian Journal of Dermatology|March 11, 2015
Adverse effects of topical corticosteroids in paediatric eczema: Australasian consensus statementEmma Mooney, Marius Rademaker, Rebecca Dailey, et al.
Journal of the American Academy of Dermatology|February 26, 2018
CARD14-associated papulosquamous eruption: A spectrum including features of psoriasis and pityriasis rubra pilarisBrittany G Craiglow, Lynn M Boyden, Ronghua Hu, et al.
American Journal of Human Genetics|March 5, 2016
Mosaic Activating Mutations in FGFR1 Cause Encephalocraniocutaneous LipomatosisJames T Bennett, Tiong Yang Tan, Diana Alcantara, et al.
The Australasian Journal of Dermatology|March 3, 2017
Consensus statement for the treatment of infantile haemangiomas with propranololSarah L Smithson, Marius Rademaker, Susan Adams, et al.
Journal of the American Academy of Dermatology|July 19, 2020
Multidisciplinary care of epidermolysis bullosa during the COVID-19 pandemic-Consensus: Recommendations by an international panel of expertsDedee F Murrell, Anne W Lucky, Julio C Salas-Alanis, et al.
The New England Journal of Medicine|February 19, 2015
A randomized, controlled trial of oral propranolol in infantile hemangiomaChristine Léauté-Labrèze, Peter Hoeger, Juliette Mazereeuw-Hautier, et al.
The World Allergy Organization Journal|August 30, 2024
The Australasian Registry for Severe Cutaneous Adverse Reactions (AUS-SCAR) - Providing a roadmap for closing the diagnostic, patient, and healthcare gaps for a group of rare drug eruptionsFiona James, Michelle S Goh, Sara Vogrin, et al.
Pageof 6